Abstract
‘In the first five years of developing Biogen, in addition to doing creative and world-class science, we had to be able to fund this work, and keep access to the financial market. This a very large challenge because you need to convince investors to take a long-range view with their investment, because drugs cannot be developed in two or three or four years like computers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Copyright information
© 1992 International Business Writing Limited
About this chapter
Cite this chapter
Jones, S. (1992). Phase III Capital: Aiming for the Top, Hitting the Big Time. In: The Biotechnologists. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-12316-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-349-12316-2_7
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-12318-6
Online ISBN: 978-1-349-12316-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)